Amitriptyline Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Amitriptyline Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

Suicidality and Antidepressant Drugs
Warnings: Clinical Worsening and Suicide RiskPrecautions: Information for PatientsPrecautions: Pediatric Use

AMITRIPTYLINE HYDROCHLORIDE DESCRIPTION


Amitriptyline Hydrochloride





CLINICAL PHARMACOLOGY




INDICATIONS & USAGE



AMITRIPTYLINE HYDROCHLORIDE CONTRAINDICATIONS






WARNINGS

Clinical Worsening and Suicide Risk:









Screening Patients for Bipolar Disorder:







PREGNANCY

Pregnancy Category C



NURSING MOTHERS




PRECAUTIONS










Information for Patients:
Medication Guide"Antidepressant Medicines, Depression and other Serious Mental Illness, and Suicidal Thoughts or Actions"



Clinical Worsening and Suicide Risk:


Drug Interactions:

Drugs Metabolized by P450 2D6

Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug. Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required. It is desirable to monitor TCA plasma levels whenever a TCA is going to be coadministered with another drug known to be an inhibitor of P450 2D6.

Monoamine oxidase inhibitors
CONTRAINDICATIONSseeWARNINGS






PEDIATRIC USE

BOX WARNINGWARNINGS-Clinical Worsening and Suicide Risk

GERIATRIC USE


DOSAGE AND ADMINISTRATION

AMITRIPTYLINE HYDROCHLORIDE ADVERSE REACTIONS











OVERDOSAGE


Gastrointestinal Decontamination:


Cardiovascular:



CNS:



Psychiatric Follow-up:


Pediatric Management:


DOSAGE & ADMINISTRATION





Initial Dosage for Adults:




Adolescent and Elderly Patients:


Maintenance:


Usage in Pediatric Patients


Plasma Levels


HOW SUPPLIED








STORAGE AND HANDLING


METABOLISM



REFERENCES




























SPL MEDGUIDE



Antidepressant Medicines, Depression and Other Serious Mental llnesses, and Suicidal Thoughts or Actions

  • ●all risks and benefits of treatment with antidepressant medicines
  • ●all treatment choices for depression or other serious mental illness
  • ●What is the most important information I should know about antidepressant medicines, depression and other serious mental illnesses, and suicidal thoughts or actions?




  • ●Call the healthcare provider right away to report new or sudden changes in mood, behavior, thoughts, or feelings.
  • ●Keep all follow-up visits with the healthcare provider as scheduled. Call the healthcare provider between visits as needed, especially if you have concerns about symptoms.
  • ●Call a healthcare provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or worry you:

  • ●attempts to commit suicide
  • ●new or worse depression
  • ●new or worse anxiety
  • ●feeling very agitated or restless
  • ●panic attacks
  • ●trouble sleeping (insomnia)
  • ●new or worse irritability
  • ●acting aggressive, being angry, or violent
  • ●acting on dangerous impulses
  • ●an extreme increase in activity and talking (mania)
  • ●other unusual changes in behavior or mood
  • ●What else do I need to know about antidepressant medicines?

  • ●Antidepressants are medicines used to treat depression and other illnesses. It is important to discuss all the risks of treating depression and also the risks of not treating it. Patients and their families or other caregivers should discuss all treatment choices with the healthcare provider, not just the use of antidepressants.
  • ●Antidepressant medicines have other side effects. Talk to the healthcare provider about the side effects of the medicine prescribed for you or your family member.
  • ●Antidepressant medicines can interact with other medicines. Know all of the medicines that you or your family member takes. Keep a list of all medicines to show the healthcare provider. Do not start new medicines without first checking with your healthcare provider.
  • ●Not all antidepressant medicines prescribed for children are FDA approved for use in children. Talk to your child's healthcare provider for more information.
  • ●Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.







PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Amitriptyline Hydrochloride



Amitriptyline Hydrochloride



Amitriptyline Hydrochloride

Amitriptyline Hydrochloride TABLET, FILM COATED

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-173(NDC:0603-2212)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE 10 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
HYPROMELLOSES
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
polyethylene glycol
polysorbate 80
SODIUM STARCH GLYCOLATE TYPE A POTATO
titanium dioxide
FD&C BLUE NO. 1

Product Characteristics

Color Size Imprint Code Shape
blue 6 mm 2101;V ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-173-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040218 2011-04-18


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.